977 related articles for article (PubMed ID: 34048922)
1. Antimicrobial resistance progression in the United Kingdom: A temporal comparison of Clostridioides difficile antimicrobial susceptibilities.
Jon J V; Mark H W; Jane F
Anaerobe; 2021 Aug; 70():102385. PubMed ID: 34048922
[TBL] [Abstract][Full Text] [Related]
2. Reference Susceptibility Testing and Genomic Surveillance of Clostridioides difficile, United States, 2012-17.
Gargis AS; Karlsson M; Paulick AL; Anderson KF; Adamczyk M; Vlachos N; Kent AG; McAllister G; McKay SL; Halpin AL; Albrecht V; Campbell D; Korhonen LC; Elkins CA; Rasheed JK; Guh AY; McDonald LC; Lutgring JD;
Clin Infect Dis; 2023 Mar; 76(5):890-896. PubMed ID: 36208202
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial resistance in Clostridioides (Clostridium) difficile derived from humans: a systematic review and meta-analysis.
Sholeh M; Krutova M; Forouzesh M; Mironov S; Sadeghifard N; Molaeipour L; Maleki A; Kouhsari E
Antimicrob Resist Infect Control; 2020 Sep; 9(1):158. PubMed ID: 32977835
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial susceptibility patterns of Clostridium difficile strains belonging to different polymerase chain reaction ribotypes isolated in Poland in 2012.
Lachowicz D; Pituch H; Obuch-Woszczatyński P
Anaerobe; 2015 Feb; 31():37-41. PubMed ID: 25242196
[TBL] [Abstract][Full Text] [Related]
5. A nationwide study of molecular epidemiology and antimicrobial susceptibility of Clostridioides difficile in South Korea.
Byun JH; Kim H; Kim JL; Kim D; Jeong SH; Shin JH; Kim YA; Shin JH; Shin KS; Uh Y
Anaerobe; 2019 Dec; 60():102106. PubMed ID: 31655214
[TBL] [Abstract][Full Text] [Related]
6. Changes in Clostridium (Clostridioides) difficile PCR-Ribotype Distribution and Antimicrobial Resistance in a German Tertiary Care Hospital Over the Last 10 Years.
Piepenbrock E; Stelzer Y; Berger F; Jazmati N
Curr Microbiol; 2019 Apr; 76(4):520-526. PubMed ID: 30805700
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial resistance in large clostridial toxin-negative, binary toxin-positive Clostridium difficile ribotypes.
Androga GO; Knight DR; Lim SC; Foster NF; Riley TV
Anaerobe; 2018 Dec; 54():55-60. PubMed ID: 30053486
[TBL] [Abstract][Full Text] [Related]
8. Whole-Genome Sequencing Reveals the High Nosocomial Transmission and Antimicrobial Resistance of Clostridioides difficile in a Single Center in China, a Four-Year Retrospective Study.
Wen X; Shen C; Xia J; Zhong LL; Wu Z; Ahmed MAEE; Long N; Ma F; Zhang G; Wu W; Luo J; Xia Y; Dai M; Zhang L; Liao K; Feng S; Chen C; Chen Y; Luo W; Tian GB
Microbiol Spectr; 2022 Feb; 10(1):e0132221. PubMed ID: 35019676
[TBL] [Abstract][Full Text] [Related]
9. Prevalence, toxin gene profile, genotypes and antibiotic susceptibility of
Saber T; Hawash YA; Ismail KA; Khalifa AS; Alsharif KF; Alghamdi SA; Saber T; Eed EM
Indian J Med Microbiol; 2020; 38(2):176-182. PubMed ID: 32883931
[TBL] [Abstract][Full Text] [Related]
10. The ClosER study: results from a three-year pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes, 2011-2014.
Freeman J; Vernon J; Pilling S; Morris K; Nicholson S; Shearman S; Longshaw C; Wilcox MH;
Clin Microbiol Infect; 2018 Jul; 24(7):724-731. PubMed ID: 29066403
[TBL] [Abstract][Full Text] [Related]
11. Surveillance of antimicrobial susceptibilities reveals high proportions of multidrug resistance in toxigenic Clostridium difficile strains in different areas of Poland.
Lachowicz D; Pituch H; Wultańska D; Kuijper E; Obuch-Woszczatyński P
Anaerobe; 2020 Apr; 62():102167. PubMed ID: 32109736
[TBL] [Abstract][Full Text] [Related]
12. Five-year Pan-European, longitudinal surveillance of Clostridium difficile ribotype prevalence and antimicrobial resistance: the extended ClosER study.
Freeman J; Vernon J; Pilling S; Morris K; Nicolson S; Shearman S; Clark E; Palacios-Fabrega JA; Wilcox M;
Eur J Clin Microbiol Infect Dis; 2020 Jan; 39(1):169-177. PubMed ID: 31811507
[TBL] [Abstract][Full Text] [Related]
13. Dogs as carriers of virulent and resistant genotypes of Clostridioides difficile.
Finsterwalder SK; Loncaric I; Cabal A; Szostak MP; Barf LM; Marz M; Allerberger F; Burgener IA; Tichy A; Feßler AT; Schwarz S; Monecke S; Ehricht R; Ruppitsch W; Spergser J; Künzel F
Zoonoses Public Health; 2022 Sep; 69(6):673-681. PubMed ID: 35546073
[TBL] [Abstract][Full Text] [Related]
14. Strain types and antimicrobial resistance patterns of Clostridium difficile isolates from the United States, 2011 to 2013.
Tickler IA; Goering RV; Whitmore JD; Lynn AN; Persing DH; Tenover FC;
Antimicrob Agents Chemother; 2014 Jul; 58(7):4214-8. PubMed ID: 24752264
[TBL] [Abstract][Full Text] [Related]
15. Ribotypes and antimicrobial susceptibility profiles of clinical Clostridioides difficile isolates: A multicenter, laboratory-based surveillance in Taiwan, 2019-2021.
Tsai CS; Lu PL; Lu MC; Hsieh TC; Chen WT; Wang JT; Ko WC
J Microbiol Immunol Infect; 2024 Apr; 57(2):320-327. PubMed ID: 38135646
[TBL] [Abstract][Full Text] [Related]
16. [In Vitro Activities of Antimicrobials Against Toxigenic Clostridioides difficile Isolates Obtained in a University Training and Research Hospital in Turkey].
Sayın E; Bilgin H; Söyletir G; Ülger Toprak N
Mikrobiyol Bul; 2020 Jul; 54(3):368-377. PubMed ID: 32755514
[TBL] [Abstract][Full Text] [Related]
17. Two Clusters of Fluoroquinolone and Clindamycin-Resistant Clostridium difficile PCR Ribotype 001 Strain Recognized by Capillary Electrophoresis Ribotyping and Multilocus Variable Tandem Repeat Analysis.
Nyc O; Tejkalova R; Kriz Z; Ruzicka F; Kubicek L; Matejkova J; Kuijper E; Krutova M
Microb Drug Resist; 2017 Jul; 23(5):609-615. PubMed ID: 27860531
[TBL] [Abstract][Full Text] [Related]
18. The tcdA-negative and tcdB-positive Clostridium difficile ST81 clone exhibits a high level of resistance to fluoroquinolones: a multi-centre study in Beijing, China.
Cheng JW; Liu C; Kudinha T; Xiao M; Fan X; Yang CX; Wei M; Liang GW; Shao DH; Xiong ZJ; Hou X; Yu SY; Wang Y; Yang QW; Su JR; Xu YC
Int J Antimicrob Agents; 2020 Jul; 56(1):105981. PubMed ID: 32330584
[TBL] [Abstract][Full Text] [Related]
19. Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolated from hospitals during a 4-year period in China.
Chen YB; Gu SL; Shen P; Lv T; Fang YH; Tang LL; Li LJ
J Med Microbiol; 2018 Jan; 67(1):52-59. PubMed ID: 29160203
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial resistance surveillance of Clostridioides difficile in Australia, 2015-18.
Putsathit P; Hong S; George N; Hemphill C; Huntington PG; Korman TM; Kotsanas D; Lahra M; McDougall R; McGlinchey A; Moore CV; Nimmo GR; Prendergast L; Robson J; Waring L; Wehrhahn MC; Weldhagen GF; Wilson RM; Riley TV; Knight DR
J Antimicrob Chemother; 2021 Jun; 76(7):1815-1821. PubMed ID: 33895826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
